The rejoinder submissions and evidence of the Canadian Government has been posted in Eli Lilly’s NAFTA Chapter 11 arbitration against the Canadian government relating to the utility of Eli Lilly’s Zyprexa and Strattera patents. Continue reading NAFTA Arbitration